The class of Gab2 activators comprises a diverse array of chemicals that intricately modulate the activation of Gab2, a pivotal signaling adaptor protein. SHP099 disrupts the negative feedback loop between SHP2 and Gab2, leading to sustained Gab2 phosphorylation and enhanced activation. sc-60, an AKT activator, directly engages the PI3K-AKT pathway, promoting Gab2 phosphorylation and augmenting its participation in downstream signaling cascades. Amuvatinib, a multi-tyrosine kinase inhibitor, indirectly activates Gab2 by inhibiting c-Kit, resulting in increased Gab2 phosphorylation and involvement in signaling networks. Agents such as LY294002 and TGX-221, targeting the PI3K pathway, indirectly modulate Gab2 by altering its phosphorylation patterns. U0126, a MEK1/2 inhibitor, disrupts the MAPK pathway, influencing Gab2 phosphorylation and enhancing its activation. PRT062607, a SYK inhibitor, indirectly activates Gab2 by modulating SYK-dependent signaling, fostering Gab2 phosphorylation and engagement in cellular responses.
Compounds like 15-Deoxy-Δ12,14-prostaglandin J2 and AZD5363, acting through PPARγ and AKT inhibition, respectively, contribute to Gab2 activation. SP600125, a JNK inhibitor, and GDC-0941, a PI3K inhibitor, indirectly modulate Gab2 by altering JNK and PI3K signaling, respectively, influencing Gab2 phosphorylation and its role in cellular responses. The dynamic interplay between these diverse activators highlights the intricacies of Gab2 regulation within signaling networks. These chemicals serve as valuable tools for researchers aiming to dissect the molecular pathways orchestrating Gab2 activation, providing insights into its multifaceted roles in cellular physiology.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002, a PI3K inhibitor, indirectly influences Gab2 by suppressing the PI3K pathway. Inhibition of PI3K hampers downstream signaling, leading to altered phosphorylation patterns of Gab2 and enhanced activation. | ||||||
15-Deoxy-δ12,14-Prostaglandin J2 | 87893-55-8 | sc-201262 sc-201262A | 1 mg 5 mg | $141.00 $551.00 | 5 | |
15-Deoxy-Δ12,14-prostaglandin J2, a PPARγ agonist, indirectly activates Gab2 by influencing PPARγ-dependent pathways. Activation of PPARγ fosters Gab2 phosphorylation, contributing to its role in cellular signaling. | ||||||
PI 3-Kβ Inhibitor VI, TGX-221 | 663619-89-4 | sc-203190 | 1 mg | $437.00 | ||
TGX-221, a PI3Kβ inhibitor, indirectly influences Gab2 by targeting the PI3K pathway. Inhibition of PI3Kβ alters the signaling cascade, leading to modified phosphorylation patterns of Gab2 and enhanced activation. | ||||||
A66 | 1166227-08-2 | sc-364394 sc-364394A | 5 mg 50 mg | $255.00 $1455.00 | ||
A66, an Akt1 inhibitor, indirectly activates Gab2 by targeting the Akt pathway. Inhibition of Akt1 influences Gab2 phosphorylation, facilitating its engagement in downstream signaling events. | ||||||
SP600125 | 129-56-6 | sc-200635 sc-200635A | 10 mg 50 mg | $40.00 $150.00 | 257 | |
SP600125, a JNK inhibitor, indirectly modulates Gab2 by suppressing the JNK pathway. Inhibition of JNK alters the signaling dynamics, affecting Gab2 phosphorylation and promoting its engagement in cellular responses. | ||||||
GDC-0941 | 957054-30-7 | sc-364498 sc-364498A | 5 mg 10 mg | $188.00 $199.00 | 2 | |
GDC-0941, a PI3K inhibitor, indirectly influences Gab2 by targeting the PI3K pathway. Inhibition of PI3K alters the signaling cascade, leading to modified phosphorylation patterns of Gab2 and enhanced activation. | ||||||
AZD5363 | 1143532-39-1 | sc-503190 | 5 mg | $309.00 | ||
AZD5363, an AKT inhibitor, indirectly activates Gab2 by inhibiting AKT. Suppression of AKT leads to sustained Gab2 phosphorylation, influencing its engagement in downstream signaling cascades. | ||||||